University of Minnesota. Driven to Discover.
Response to seasonal flu, H7N9, MERS, and other threats could be markedly diminished.
Key public health tasks, like flu surveillance, science communication, and lab testing, have resumed.
Public health groups are lining up to oppose 'piecemeal' efforts to fund federal agencies.
Clinical trials will test a candidate vaccine for H7N9 flu in varying doses, some with immune boosters.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
Become an underwriter»
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.